You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 210660


✉ Email this page to a colleague

« Back to Dashboard


NDA 210660 describes ELCYS, which is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug. Additional details are available on the ELCYS profile page.

The generic ingredient in ELCYS is cysteine hydrochloride. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteine hydrochloride profile page.
Summary for 210660
Tradename:ELCYS
Applicant:Exela Pharma
Ingredient:cysteine hydrochloride
Patents:16
Suppliers and Packaging for NDA: 210660
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELCYS cysteine hydrochloride SOLUTION;INTRAVENOUS 210660 NDA Exela Pharma Sciences, LLC 51754-1007 51754-1007-1 10 mL in 1 VIAL (51754-1007-1)
ELCYS cysteine hydrochloride SOLUTION;INTRAVENOUS 210660 NDA Exela Pharma Sciences, LLC 51754-1007 51754-1007-3 100 mL in 1 CARTON (51754-1007-3)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength500MG/10ML (50MG/ML)
Approval Date:Apr 16, 2019TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Jan 15, 2039Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF USING L-CYSTEINE IN AN ADMIXTURE FOR TREATING PATIENTS NEEDING PARENTERAL NUTRITION
Patent:⤷  Sign UpPatent Expiration:Jan 15, 2039Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF USING L-CYSTEINE IN AN ADMIXTURE FOR TREATING PATIENTS NEEDING PARENTERAL NUTRITION
Patent:⤷  Sign UpPatent Expiration:Jan 15, 2039Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.